Safety and Efficacy Study of Topical Methyaminlevulinate (MAL) in Subjects With Facial Acne
Status:
Completed
Trial end date:
2008-07-01
Target enrollment:
Participant gender:
Summary
A study of safety and efficacy of topical methyaminlevulinate 80mg/g with and without
occlusion followed by red light exposure in subjects with facial acne.